Table 4.

Comparison of study characteristics with other studies[2, 4, 5, 17]

	Tilly et al.	Mytelka et al.	Nair et al.	Gogia et al.	Present study
No. of patients	879	257	1961	417	55
Regimen	Pola-R-CHP- 440 RCHOP- 439	RCHOP (80%)	RCHOP (68%)	RCHOP	RfCHOP- 28 RCHOP- 27
B symptoms	-		43%	43%	64%
High Intermediate/ High IPI	62%	100%	30%	19% (High risk)	51%
Bulky Disease	43.8%			32%	46%
Non-GCB Subtype	33%	-	54%	47%	67%
Stage III/IV	88.7%	89%	57%	51%	69%
CR	Pola-RCHP- 78% RCHOP-74%	77%	67%	75%	RfCHOP- 82% RCHOP- 59%